Tumor promotion by γ and suppression by β non-muscle actin isoforms

Area of Science:

• Cell Biology
• Molecular Oncology
• Biochemistry

Background:

• Non-muscle actins, beta-cytoplasmic (β-actin) and gamma-cytoplasmic (γ-actin), are typically viewed as housekeeping proteins.
• Dysregulation of actin cytoskeleton dynamics is implicated in various cancers.
• The specific roles of β- and γ-actin isoforms in oncogenesis remain incompletely understood.

Purpose of the Study:

• To investigate the distinct roles of β- and γ-cytoplasmic actin isoforms in cancer progression.
• To identify potential molecular targets and biomarkers for cancer therapy based on actin isoform expression.

Main Methods:

• In vitro cell culture experiments assessing cell growth and invasion.
• In vivo tumor growth studies in animal models.
• Analysis of signaling pathways including ERK1/2, p34-Arc, WAVE2, and cofilin1.

Main Results:

• β-cytoplasmic actin demonstrated tumor suppressor activity, inhibiting cell growth, invasion, and tumor growth.
• γ-cytoplasmic actin enhanced oncogenic potential, correlating with increased expression of ERK1/2, p34-Arc, WAVE2, and cofilin1.
• A positive feedback loop was identified between γ-actin expression and ERK1/2 activation.

Conclusions:

• Non-muscle actin isoforms possess distinct regulatory functions beyond housekeeping roles.
• The ratio of β/γ-actin expression can serve as an oncogenic marker, particularly in lung and colon carcinomas.
• Therapeutic strategies aimed at modulating β- and/or γ-actin expression hold promise for anticancer treatment.